All posts by: Michael Zand

About Michael Zand

World-First Embryonic Stem Cell Trial for the Heart – Bioscience Technology

Continue reading

2014-10-31 NEWS

Bioscience Technology

World-First Embryonic Stem Cell Trial for the Heart
Bioscience Technology
The first embryonic stem (ES) cell trial for severe heart failure is launching now in Paris. The long-awaited trial comes after much preclinical cell work on more than 350 rats, 50 immunodeficient mice and 32 non-human primates. “After 20 years in the

Continue reading

2014-10-31 NEWS

Medical News Today

Study of stem cell origins sheds new light
Medical News Today
“Now we know Sox2 is the first indicator that a cell is pluripotent. In fact, Sox2 may be the pre-pluripotent gene. We show that Sox2 is detectable in just one or two cells of the embryo earlier than previously thought, and earlier than other known
Research Sheds Light on Source of Stem CellsLaboratory Equipment
Identifying the source of stem cellsEureka! Science News

all 5 news articles »

Continue reading

2014-10-31 NEWS

Medical News Today

‘Yorkie and Scalloped’ – genes that prime stem cells for fighting infection
Medical News Today
“This study can further our shared understanding of how the microenvironment can regulate the differentiation and fate of a progenitor or stem cell,” Dr. Ferguson says. In February of this year, researchers at the University of Chicago reported in the
UCLA scientists release immune system-related gene studyWestside Today

all 2 news articles »

Continue reading

2014-10-31 NEWS

Stem cell therapy for diabetes
OUPblog (blog)
This month, it was reported that scientists at Harvard University have successfully made insulin-secreting beta cells from human pluripotent stem cells. This is an important milestone towards a “stem cell therapy” for diabetes, which will have huge

Continue reading

2014-10-31 NEWS

Stem cell therapy for diabetes
OUPblog (blog)
This month, it was reported that scientists at Harvard University have successfully made insulin-secreting beta cells from human pluripotent stem cells. This is an important milestone towards a “stem cell therapy” for diabetes, which will have huge